Study Finds Risk Of Medication Discontinuation Is Greatest For New Patients At The Start Of Therapy

In a new study published online today by Clinical Therapeutics, researchers from Adheris, Inc., an inVentiv Health company, found that patients new to chronic disease medication face the greatest risk of medication discontinuation during the first 30 days of treatment--with rates of discontinuation ranging from 29.6% to 78.1%.